Objective: To report 21 yrs of experience with pediatric flexible fiberoptic bronchoscopy in infants and children, explore newer applications, delineate potential complications, and make recommendations for its future application.
Flexible fiberoptic bronchoscopy in children and infants has been integrated into the practice of pediatrics in the past two decades ( ). Previously considered, by some, a mere clinical stunt, it is now recognized and accepted as a diagnostic and, to a certain degree, therapeutic modality in a myriad of respiratory disorders.
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In the late 1970s, Robert E. Wood began promoting the direct examination of the tracheobronchial tree with specially constructed, flexible fiberoptic bronchoscopes (FFBs) suitable for use in infants and children ( ). He is credited with laying the foundation for pediatric flexible fiberoptic bronchoscopy (PFFB), and largely because of those initial efforts, the technique greatly facilitated the diagnosis and management of respiratory tract disorders and broadened the scope of pediatric pulmonology during the 1980s. Despite its increased use, the procedure of PFFB continues to evolve and appropriately requires an update to make its applications fitting for the coming decade. It is the purpose of this article to share our experience with 2,836 bronchoscopies from July 1979 through July 2000, provide new directions, dispel certain myths, and allow untraditional considerations for the use of PFFB. This article will explore interventional usefulness of PFFB and suggest newer directions for the method of sedation or anesthesia to be employed in consideration of risks and life-threatening complications unveiled in our clinical report.
7, 8 SUBJECTS AND METHODS TOP
A total of 2,836 pediatric patients (1,536 girls) were subjected to diagnostic or interventional flexible fiberoptic bronchoscopy.
Procedure and Monitoring. TOP
A variety of FFBs of appropriate size for our subjects were employed, as previously described ( ). Six hours with nothing by mouth was required for all infants and children before bronchoscopy. An intravenous catheter was secured, and detailed consent was obtained from DISCUSSION 
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Figures/ Tables  Table 1  Table 2  Table 3  Table 4  Table 5  Table 6 each patient. The consent form delineated potential risks and complications balanced against targeted objectives and benefits. The nasopharynx, usually the right side, was topically anesthetized by applying 0.3-2.5 ml of 2% lidocaine solution, not exceeding 2 mg/kg, followed by local lubrication with lidocaine jelly. With the exception of tracheostomy evaluation or endotracheal introduction in ventilated children, procedures were performed transnasally. Evaluation of optimal positive end expiratory pressure and bilevel positive airway pressure in tracheostomized children with tracheomalacia or obstructive apnea, and in those who required intubation, was accomplished with an ultrathin bronchoscope (outer diameters of 1.8 and 2.2 mm). The instrument was introduced through a thin membrane that sealed an adapter that was connected to the tracheostomy or endotracheal tube. The instrument simply punctured the thin membrane, allowing evaluation in an air leak-free compartment. Tracheal lumen diameter and changes in the diameter of the right and left main stem bronchi were observed, recorded, and photographed as changes in positive end expiratory pressure or bilevel positive airway pressure were made. Concurrent and continuous measurements of oxygen saturation and end-tidal CO were obtained. It allowed an appreciation of the optimal large-airway diameter associated with the best oxygen saturation and end-tidal CO as the level of positive end expiratory pressure or bilevel positive airway pressure was adjusted. 2 2 Peripheral perfusion and depth of respirations were closely monitored by a registered nurse.
Respirations were also monitored electronically. Blood pressure, electrocardiogram, and oxygen saturation by a pulse oximeter were monitored in all patients. Those who experienced a fall in oxygen saturation below 95% were given oxygen by mask that specially fenestrated to accommodate the introduction of the bronchoscope.
Sedation and General Anesthesia. TOP
Intravenous sedation allowed the patient to remain reasonably comfortable while ventilation and oxygenation remained adequate. Those objectives were accomplished from the late 1970s through the 1980s with a combination of 1 mg/kg meperidine with 1 mg/kg promethazine and 1 mg/kg chlorpromazine ( ). During the 1990s, we used the relatively short-acting fentanyl, 1 Î1⁄4g/kg, intravenously, followed 10 mins later by 0.1 mg/kg intravenous midazolam to a maximum of 2.5 mg per dose, given slowly over 2 mins. Ketamine, 1 mg/kg, or propofol were used if the above modalities failed to achieve appropriate sedation for the procedure. In patients who experienced a decrease in oxygen saturations to <85% and showed evidence of respiratory depression despite oxygen supplementation, the effects of fentanyl were reversed by naloxone, and the effects of midazolam were reversed by flumazenil. All procedures were performed in the pediatric intensive care unit (PICU) or the operating room. When general anesthesia was provided, the flexible fiberoptic bronchoscope was introduced via a customized adapter through an appropriate endotracheal tube or a laryngeal mask airway (LMA) ( ).
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Indications. TOP In previous communications, a detailed list of indications for PFFB were delineated ( ). Our experience of more than two decades has helped develop an expanded and updated repertoire of indications for flexible fiberoptic bronchoscopy in children. There was a preference to separate those indications into two major categories ( ). Flexible fiberoptic bronchoscopy for the evaluation of a potential foreign body in the airway was purposefully not mentioned because the author firmly believes that when such suspicion arises, even a remote one, the possibility of foreign body aspiration should be explored with a rigid bronchoscope (open tube, ventilating tube bronchoscope) in the operating room, except in special circumstances ( ). Similarly, acute epiglottitis previously cited as an indication was omitted from the list in consideration of its extreme rarity in children who are currently immunized with a B vaccine ( ). With recent advances in airway instrumentation and ventilatory support systems, newer indications are included for the category of medical disorders, such as plastic bronchitis of acute chest syndrome in sickle cell disease or asthma ( ). Table 1 14, 15
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Hemophilus influenzae 
Contraindications. TOP
Severe hypoxemia (P o < 50 mm Hg), bleeding diathesis, severe hemoptysis, hemodynamic instability, or arrhythmia and extreme upper airway obstruction should exclude patients from bedside bronchoscopy. However, if the patient is already intubated, flexible fiberoptic bronchoscopy can be accomplished in the PICU or the operating room. Adequate ventilation (P co < 45 mm Hg) and oxygenation (P o > 60 mm Hg; oxygen saturation, >90%) should be the minimum requirements providing diagnostic or interventional bronchoscopy are absolutely necessary life-saving measures. Age distribution is shown in . The youngest subject who underwent bronchoscopy was a 1-wk-old, 600-g, premature infant with distal tracheal obstruction evaluated with an ultrathin bronchoscope. Because assessment of upper airway abnormality does not exclude the possibility of subglottic or lower airway lesions, we proceeded with inspection of the lower airway. Nineteen percent of our subjects were <12 months of age. A total of 198 children required general anesthesia by either endotracheal intubation or the LMA, which has been used since 1996. Recovery to baseline was usually accomplished within 60 mins after anesthesia. Diagnoses of the lower and upper airways that were enhanced by fiberoptic bronchoscopy are listed in , respectively. Although the cardinal diagnosis for each patient is listed, certain patients were afflicted with more than one abnormality or disease category, hence, the discrepancy between the number of bronchoscopies and diagnoses. Similarly, a few patients, representing <5% of our population, required more than a single bronchoscopy procedure. Each repeat procedure was counted as a separate bronchoscopy, and the patient's profile (age, sex) was added separately. Laryngomalacia, adenoidal hypertrophy, and subglottic narrowing constitute the most common upper airway abnormalities, whereas normal anatomy, inflammatory changes, and thick bronchial secretions or mucoid impaction represent the main findings in lower airways. Tables 3 and 4 Table 3 . Diagnoses of lower airway TOP A total of 411 of 1705 bronchoalveolar lavage (BAL) cultures (24%) from patients with purulent secretions and inflammatory changes had positive microbiologic identification that resulted in a targeted antimicrobial regimen ( ). Fifteen percent of BAL from patients with cystic fibrosis colonized with or species, and 6% of severe asthmatics were also positive for species, primarily Confirmation of allergic bronchopulmonary in those individuals mandated treatment with systemic oral steroids and a 2-6 month course of itraconazole. Viral identification was accomplished by direct fluorescent antibody technique, and confirmation by viral cultures was obtained in critically ill infants or those intubated and mechanically ventilated in the PICU. Six infants with respiratory syncytial virus had concurrent infection with influenza A (2 cases), and the other four were also infected with parainfluenza III. Viral identification avoided unnecessary antimicrobial treatment. Table 5 Staphylococcus aureus Pseudomonas Aspergillus Aspergillus fumigatus. Aspergillosis Table 5 . Microbiological identification Cytology and Ultrastructure. TOP Primary dyskinetic cilia syndrome was diagnosed in 5 of 12 individuals by subjecting transbronchial biopsy specimens to electron microscopy examination. Outer dynein arms were missing in peripheral microtubules in all five specimens. All 12 individuals had chronic productive cough, recurrent otitis media, recurrent pulmonary infiltrates, and pansinusitis as determined by computed tomographic scans. In all 12 individuals, microbial or infectious agents could not be identified, immunodeficiency disorder was ruled out, two sweat chloride tests in each were normal, and DNA analysis for cystic fibrosis mutations were negative. Transbronchial biopsy in the remaining patients was unrevealing. Hemosiderin-laden alveolar macrophages from BAL helped confirm the diagnosis of pulmonary hemosiderosis in nine patients, and lipid-laden alveolar macrophages assisted in the diagnosis of aspiration secondary to gastroesophageal reflux disorder ( ). An increased percentage of eosinophils in BAL was commonly found in asthmatics during acute exacerbation or in those who were noncompliant or poorly managed ( ).
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Plastic Bronchitis in Acute Chest Syndrome of Sickle Cell Disease. TOP Among the pediatric inpatients diagnosed with acute chest syndrome of sickle cell disease who underwent bronchoscopy, plastic bronchitis was diagnosed in 21 of 29 episodes (72%). Ages ranged from 3 to 20 yrs old (median age, 8 yrs; 15 female patients). Of that, 24 patients had homozygous sickle cell disease and the rest had sickle-hemoglobin C disease. All patients presented with fever, cough, chest pain, and pulmonary consolidation on chest roentgenogram ( ). Plastic bronchitis was diagnosed by bronchoscopy and characterized as white, gray, yellow, rubbery casts branching into the bronchial tree. These bronchial casts were surrounded by thin, bright-yellow fluid identical to bilirubin in gross appearance. The locations of the casts corresponded to the radiographic findings. In certain bronchial segments, mucoid impaction was identified. Details of pathologic findings from BAL are listed in . As we previously described, bronchoscopy and BAL were beneficial in guiding specific therapy when added to currently practiced supportive care. We avoided the inappropriate use of antibiotics with retrieval of secretions and mucoid impaction and prevented further deterioration of ventilation-perfusion abnormalities and hypoxemia previously described. Table 6 8/17/06 9:21 AM Table 6 . Results of BAL in plastic bronchitis in acute chest syndrome of sickle cell disease PFFB with LMA. TOP LMA was deployed when control of the airway, under general anesthesia, was needed, but endotracheal intubation was not required for passage of the bronchoscope. A total of 92 children (51 girls), ages 1-15 yrs, were subjected to PFFB because of persistent or recurrent atelectasis with or without pneumonia or diffuse infiltrates ( ). The size of LMA was chosen to accommodate an FFB appropriate for the child's or infant's airway. None of our subjects experienced any complication such as arrhythmia, hypotension, or hypoxemia. The procedure, devoid of endotracheal intubation, provided an optimal setting with maximal patient comfort.
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Clinical Utility in Airway Management. TOP PFFB was instrumental in the following areas:
1. Inspection of airways, primarily the trachea, before decannulation of tracheostomy tube or a change of tracheostomy tube to a smaller or larger size as clinically indicated.
2. In 16 cases of severe tracheomalacia, the FFB was deployed to measure the exact length from the tracheostomy skin stoma to carina. This enabled the PICU staff to order a custom-made tracheostomy tube with specified dimensions (Bivona or Shiley) that could serve as an effective stent ( ). Complications. TOP We did not experience any fatalities, but 21 individuals (ages, 2 months to 15 yrs) experienced transient, although significant, oxygen desaturations (oxygen saturations, 65% to 80%), and of those, five individuals required emergency endotracheal intubations. The other 16 patients improved with oxygen supplementation, and the bronchoscope was promptly withdrawn from the airway. Recorded age-adjusted tachycardia or bradycardia were only transient and did not deteriorate to a life-threatening arrhythmia. None of the patients became hypotensive, and in all 21 individuals, the effect of fentanyl was reversed by naloxone and that of midazolam by flumazenil. Nineteen of the 21 children received intravenous fentanyl in concert with midazolam in the PICU, and two individuals received ketamine. Two of the five intubated patients (a 3-monthold infant girl and an 8-yr-old girl) experienced apnea before the procedure began because of fentanyl-induced chest wall rigidity or respiratory depression from the combined regimen of fentanyl and midazolam. The other three intubated individuals, aged 10-15 yrs, had pulmonary infiltrates with atelectasis, required suction for BAL, and experienced severe decreases in oxygen saturation during the procedure. All recovered without any sequelae. None of the patients undergoing general anesthesia suffered any complication. Mild nasopharyngeal bleeding was seen in 4% of our patients and was attributed to local trauma rather than thrombocytopenia or coagulopathy. Transient stridor was always mild and resolved within 12 to 24 hrs after
In addition, laryngospasm or bronchospasm was observed in 17 individuals (0.6%) who underwent the BAL procedure, and it was promptly mitigated with inhaled albuterol (0.5%), oxygen supplementation, and ambubagging (six individuals) with 100% oxygen. Those six individuals experienced severe oxygen desaturation (<80%) and represent a subgroup of the 21 patients listed above.
DISCUSSION TOP
Our clinical report explores the diagnostic usefulness of flexible fiberoptic bronchoscopy in infants and children balanced against its potential risks and complications. Newer applications, on the basis of our experience, include early intervention in plastic bronchitis during acute chest syndrome of sickle cell disease, diagnostic biopsy in suspected dyskinetic cilia syndrome, incorporation of LMA during bronchoscopy, guiding surgery after thermal injury or traumatic tear of a major bronchus, deployment of an ultrathin bronchoscope in the neonatal intensive care unit for inspection of airway patency and tube position in extremely premature infants, and evaluation or adjustment of tracheostomy tubes. Those listed applications helped change the course of therapy in our patient population, as did the cytologic and microbiologic results of BAL, in guidance toward targeted treatments and avoidance of inappropriate use of antimicrobial agents. The cytologic and microbiologic results of BAL were of particular importance in the diagnosis of pulmonary infiltrates in immunocompromised children, those with pulmonary hemosiderosis, and those with gastroesophageal reflux disorder. Persistent or recurrent stridor and unexplained chronic cough or wheezing with pulmonary infiltrates constituted the most common indications for bronchoscopy. Only 24% of BAL specimens yielded positive cultures, Pediatric flexible fiberoptic bronchoscopy is a safe diagnostic and interventional tool in children, including extremely premature infants.
which guided further antimicrobial therapy. In those with stridor or abnormal phonation, bronchoscopy triggered consultation with ear, nose, and throat specialists with or without surgical intervention in approximately 30% of the cases with subglottic narrowing or enlarged adenoidal tissue. In the remaining 70%, assurance was given to the parents of those with a normal larynx or laryngomalacia ( ). The utilization of the ultrathin FFB (1.8 or 2.2 mm in diameter) provided an appreciation of the dynamic state of the upper airways in their natural state, devoid of disruption from general anesthetic agents or the oral approach with the rigid bronchoscope ( ). We found it particularly helpful in patients with laryngomalacia and vocal cords dysfunction, which constituted 56% of all upper airway diagnoses. We did not experience the entire range of complications reported by others, although disturbance of ventilation-perfusion relationships as a major cause of hypoxemia was recognized in our experience ( ). We did not encounter any fatality in our 21 yrs of experience, but 21 individuals (<1%) experienced significant hypoxia and five required endotracheal intubation ( ). Significant hemodynamic consequences, secondary to hypoxia, were not recorded, probably because of prompt intervention in the PICU, although the potential for such adverse effects certainly exists and must be recognized when heavy sedation in the PICU is considered. Complications from local application of lidocaine solution (1% or 2%) have been reported by others, but they were not observed in our patients ( ). 
26
It is certainly true that, in a myriad of circumstances, diagnostic pediatric fiberoptic bronchoscopy represents an attractive and safe alternative to open rigid-tube bronchoscopy. However, one should remain cognizant of the potential for serious adverse effects ( ). The perception that bedside bronchoscopy is always suitable for BAL procedures or extraction of mucoid impaction may generate a sense of false security on the basis of our experience. It requires modifications and calls for provisions that provide a secured and controlled airway, either in the operating theatre, under general anesthesia, or in the PICU. None of the patients experienced any complication when general anesthesia was employed. When bedside sedation was administered, a few children, albeit a small percentage of this large population, experienced severe hypoxia or hypoxemia that required urgent intervention.
32-34
We recommend that fentanyl, either alone or in concert with midazolam, should not be given to infants younger than 3 months of age for fear of respiratory depression or chest wall rigidity. Topical anesthetic agents such as 1% or 2% lidocaine solutions may suffice, particularly when evaluation of the upper airway or tracheostomy tube is the main objective. General anesthesia may obscure abnormal airway dynamics ( ).
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Removal of mucoid impaction or tenacious secretions in cases of bronchial obstruction, lobar atelectasis, or chronic pulmonary infiltrates should not be attempted with deep sedation as a bedside modality, but rather accomplished in the operating room under general anesthesia or while the patient is intubated in the PICU. For a prolonged procedure (>30 mins) endotracheal intubation is preferred. For a limited BAL procedure, LMA may be adequate.
The approach to patients with extensive lobar atelectasis, ventilation-perfusion mismatch, and hypoxia remains a source of debate ( ). The superiority of interventional bronchoscopy to that of conventional airway clearance techniques remains unsettled. In contrast, patients with massive atelectasis who are already intubated and mechanically ventilated should benefit from targeted removal of peripheral secretions or plugs under direct vision because blind conventional suctioning may reach secretions situated only above the carina. Restoration of lost functional volume with improvement of the ventilation-perfusion relationship, reduction of the intrapulmonary shunt, and improved gas exchange should be the main objectives of such intervention. The diagnostic application of bronchoscopy in hemoptysis was previously reported. It has long been concluded that flexible fiberoptic bronchoscopy is practically useless in severe cases of hemoptysis. The source of bleeding cannot be visualized adequately because blood obscures the working field and the specimens extracted during active bleeding have minimal if any clinical value.
We conclude that pediatric flexible fiberoptic bronchoscopy is a safe diagnostic and interventional tool in children, including extremely premature infants. We found it most applicable to the diagnosis of upper-airway obstruction in infants and in the cytologic and microbiologic identification in children with chronic cough and persistent pulmonary infiltrates. Its use for diagnostic biopsy and plastic bronchitis of acute chest syndrome is relatively new and allows targeted therapy because microbiologic identification through BAL prevents unnecessary use of antibiotics. Its clinical utility in airway management, such as tracheostomy tubes, deserves further exploration, considering that our experience is limited and requires validation by other investigators. Although the rate of serious complications in our report was low, we recommend general anesthetic agents and incorporation of the LMA in the operating room for chronic pulmonary infiltrates, severe mucoid impaction, and transbronchial biopsy.
